Toxic shock syndrome primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 6: | Line 6: | ||
== Primary Prevention == | == Primary Prevention == | ||
* The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating. | * The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating.<ref name="urlGroup A Strep | Group A Streptococcus Diseases | GAS | CDC">{{cite web |url=https://www.cdc.gov/groupastrep/diseases-public/index.html |title=Group A Strep | Group A Streptococcus Diseases | GAS | CDC |format= |work= |accessdate=}}</ref> | ||
* Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently. | * Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently. | ||
Line 15: | Line 15: | ||
* It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate. | * It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate. | ||
Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks | Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks | ||
* Experimental staphylococcal vaccines and immunotherapies in clinical trials. | * Experimental staphylococcal vaccines and immunotherapies in clinical trials. | ||
PMCID: | PMCID: <ref name="pmid21625323">{{cite journal |vauthors=Lin YC, Peterson ML |title=New insights into the prevention of staphylococcal infections and toxic shock syndrome |journal=Expert Rev Clin Pharmacol |volume=3 |issue=6 |pages=753–767 |year=2010 |pmid=21625323 |pmc=3102526 |doi=10.1586/ecp.10.121 |url=}}</ref> | ||
===Template=== | ===Template=== | ||
====Primary Prevention==== | ====Primary Prevention==== |
Revision as of 15:30, 15 May 2017
Toxic shock syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic shock syndrome primary prevention On the Web |
American Roentgen Ray Society Images of Toxic shock syndrome primary prevention |
Risk calculators and risk factors for Toxic shock syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Toxic shock syndrome (TSS) can be prevented by hygiene increase.
Primary Prevention
- The spread of all types of group A streptococcal infections can be reduced by good hand washing, especially after coughing and sneezing and before preparing foods or eating.[1]
- Menstrual toxic shock syndrome can be prevented by avoiding the use of tampons, especially the super absorbent variety. Risk can be reduced by changing tampons more frequently.
- Patients with confirmed strep throat should stay at home until 24 hours after commencing antibiotic treatment.
- All wounds should be kept clean and watched for possible signs of infection such as redness, swelling, drainage, and pain at the wound site.
- It is not necessary for all people exposed to someone with an invasive group A streptococcal TSS to receive antibiotic therapy to prevent infection. However, in certain circumstances, antibiotic therapy may be appropriate.
Avoiding extended tampon use has decreased the incidence of staphylococcal TSS. Lack of seroconversion after an acute staphylococcal illness may be used as a marker for patients at risk for recurrent disease. These patients should be treated for a protracted course with antistaphylococcal antibodies for at least 2 weeks
- Experimental staphylococcal vaccines and immunotherapies in clinical trials.
PMCID: [2]
Template
Primary Prevention
- First Sentences
- There are no primary preventive measures available for [disease name].
- OR
- There is no established method for prevention of [disease name].
- OR
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- OR
- [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
- OR
- There are no available vaccines against [disease name]. Primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- First Sentences:
- Secondary prevention strategies following [disease name] include [strategy 1], [strategy 2], and [strategy 3].
OR
- The primary and secondary prevention strategies for [Disease Name] are the same.
Prevention
- Describe in detail the key methods of preventing the disease you are describing, and preventing conditions that lead up to the disease.
- A good source to reference is http://www.uspreventiveservicestaskforce.org/index.html.
- For an example of the prevention segment in the prevention page, click here.
- Methods of prevention can be divided into primary and secondary prevention measures, as per the microchapter navigation template. To help you determine what type of preventative measures you are describing, refer to the table below.
References
- ↑ "Group A Strep | Group A Streptococcus Diseases | GAS | CDC".
- ↑ Lin YC, Peterson ML (2010). "New insights into the prevention of staphylococcal infections and toxic shock syndrome". Expert Rev Clin Pharmacol. 3 (6): 753–767. doi:10.1586/ecp.10.121. PMC 3102526. PMID 21625323.